We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
QUIA.ST

Price
0.02
Stock movement up
+0.01 (77.06%)
Company name
QuiaPEG Pharmaceuticals Holding AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
28.76M
Ent value
34.07M
Price/Sales
5.76
Price/Book
0.83
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-38.16%
1 year return
-64.78%
3 year return
-53.78%
5 year return
-
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

QUIA.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales5.76
Price to Book0.83
EV to Sales6.82

FINANCIALS

Per share

Loading...
Per share data
Current share count1.49B
EPS (TTM)-0.04
FCF per share (TTM)-0.02

Income statement

Loading...
Income statement data
Revenue (TTM)4.99M
Gross profit (TTM)3.69M
Operating income (TTM)-13.57M
Net income (TTM)-13.86M
EPS (TTM)-0.04
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)73.94%
Operating margin (TTM)-271.78%
Profit margin (TTM)-277.59%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.58M
Net receivables0.00
Total current assets4.32M
Goodwill0.00
Intangible assets37.98M
Property, plant and equipment0.00
Total assets42.57M
Accounts payable2.97M
Short/Current long term debt3.33M
Total current liabilities7.89M
Total liabilities7.89M
Shareholder's equity34.68M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-6.86M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-6.86M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-39.97%
Return on Assets-32.56%
Return on Invested Capital-36.47%
Cash Return on Invested Capital-18.04%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.01
Daily high0.03
Daily low0.01
Daily Volume345M
All-time high2.49
1y analyst estimate-
Beta0.44
EPS (TTM)-0.04
Dividend per share-
Ex-div date30 Mar 2017
Next earnings date-

Downside potential

Loading...
Downside potential data
QUIA.STS&P500
Current price drop from All-time high-99.22%-12.89%
Highest price drop-99.87%-56.47%
Date of highest drop5 Mar 20259 Mar 2009
Avg drop from high-82.41%-11.07%
Avg time to new high1171 days12 days
Max time to new high1170 days1805 days
COMPANY DETAILS
QUIA.ST (QuiaPEG Pharmaceuticals Holding AB) company logo
Marketcap
28.76M
Marketcap category
Small-cap
Description
Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Employees
3
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found